Novel nanomedicines for diagnosis and therapy

Active Research Project
Investigator(s): 
Ching H. Tung, Ph.D.
Last Updated: 
June 7, 2022

By hitting multiple action mechanisms, combination therapy efficiently tackles cancer; however, drugs administered, simultaneously or sequentially, may not reach the targeted sites with the desired dose and ratio. The Tung lab develops various strategies to improve delivery efficiency and integrated therapeutic benefit; these strategies have been applied to multidrug combination therapy, self-catalyzing photodynamic therapy, and antioxidant nanomedicine.   

Publications: A hybrid nanogel to preserve lysosome integrity for fluorescence imaging, ACS Nano: 2021, 15, 16442–16451 (PMID: 34612039); A multiresponsive nanohybrid to enhance lysosomal delivery of oxygen and photosensitizers, Chemistry: 2019, 25, 12801-12809 (PMID: 31381210).

Carousel Film 1 Ching site

Cancer targeting nanobombs
To the left: lysosome explosions caused by precise nanobombs generated by the Ching Tung lab.

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065